Tauroursodeoxycholic acid

Tauroursodeoxycholic acid is a lipid of Sterol Lipids (ST) class. Tauroursodeoxycholic acid is associated with abnormalities such as Hyperglycemia, Obesity, Wiskott-Aldrich Syndrome, neurogenic hypertension and Cholestatic liver disease. The involved functions are known as Cell Death, Apoptosis, Homeostasis, Process and mRNA Expression. Tauroursodeoxycholic acid often locates in Body tissue, Endoplasmic Reticulum, Hepatic, Blood and Protoplasm. The associated genes with Tauroursodeoxycholic acid are Homologous Gene and Mutant Proteins. The related lipids are cholanic acid, taurolithocholic acid 3-sulfate, Sterols, 7-dehydrocholesterol and tauromuricholic acid. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of Tauroursodeoxycholic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Tauroursodeoxycholic acid?

Tauroursodeoxycholic acid is suspected in Endothelial dysfunction, Hyperglycemia, Obesity, neurogenic hypertension, Cholestatic liver disease, Heart failure and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tauroursodeoxycholic acid

MeSH term MeSH ID Detail
Insulin Resistance D007333 99 associated lipids
Hypertension D006973 115 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with Tauroursodeoxycholic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Tauroursodeoxycholic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Tauroursodeoxycholic acid?

Disease model

Disease model are used in the study 'Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.' (Cortez LM et al., 2015).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Tauroursodeoxycholic acid

Download all related citations
Per page 10 20 50 100 | Total 531
Authors Title Published Journal PubMed Link
Dikkers A et al. Scavenger receptor BI and ABCG5/G8 differentially impact biliary sterol secretion and reverse cholesterol transport in mice. 2013 Hepatology pmid:23401258
Pandak WM et al. Regulation of oxysterol 7alpha-hydroxylase (CYP7B1) in primary cultures of rat hepatocytes. 2002 Hepatology pmid:12029625
Azzaroli F et al. Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes. 2002 Hepatology pmid:12085348
Gohlke H et al. α5 β1-integrins are sensors for tauroursodeoxycholic acid in hepatocytes. 2013 Hepatology pmid:22865233
Cruz LN et al. Regulation of multidrug resistance-associated protein 2 by calcium signaling in mouse liver. 2010 Hepatology pmid:20578149
Lawless MW et al. Tauroursodeoxycholic acid: relieving the pathogenesis of HFE C282Y hereditary hemochromatosis. 2008 Hepatology pmid:18203149
Schoemaker MH et al. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. 2004 Hepatology pmid:15185297
Mühlfeld S et al. Short-term feedback regulation of bile salt uptake by bile salts in rodent liver. 2012 Hepatology pmid:22806967
Kitani K et al. Tauro alpha-muricholate is as effective as tauro beta-muricholate and tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the rat. 1994 Hepatology pmid:8138240
Loria P et al. Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans. 1997 Hepatology pmid:9185744
Krähenbühl S et al. Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria. 1994 Hepatology pmid:7982660
Pak JM and Lee SS Vasoactive effects of bile salts in cirrhotic rats: in vivo and in vitro studies. 1993 Hepatology pmid:8225224
Ohiwa T et al. Tauroursodeoxycholate and tauro-beta-muricholate exert cytoprotection by reducing intrahepatocyte taurochenodeoxycholate content. 1993 Hepatology pmid:8383089
Beuers U β1 integrin is a long-sought sensor for tauroursodeoxycholic acid. 2013 Hepatology pmid:23456677
Colell A et al. Tauroursodeoxycholic acid protects hepatocytes from ethanol-fed rats against tumor necrosis factor-induced cell death by replenishing mitochondrial glutathione. 2001 Hepatology pmid:11679967
Xie Q et al. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. 2002 Hepatology pmid:12198651
Sakisaka S et al. Tubulovesicular transport of horseradish peroxidase in isolated rat hepatocyte couplets: effects of low temperature, cytochalasin B and bile acids. 1994 Hepatology pmid:7927203
Miller SD et al. Tauroursodeoxycholic acid inhibits apoptosis induced by Z alpha-1 antitrypsin via inhibition of Bad. 2007 Hepatology pmid:17559149
Alpini G et al. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha. 2002 Hepatology pmid:11981754
Wei H et al. ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones. 2008 Hum. Mol. Genet. pmid:17989065
Galán M et al. A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus. 2012 Hypertension pmid:22665120
Peterson TC et al. The inhibitory effect of ursodeoxycholic acid and pentoxifylline on platelet derived growth factor-stimulated proliferation is distinct from an effect by cyclic AMP. 1998 Immunopharmacology pmid:9754904
Fulda S et al. Cellular stress responses: cell survival and cell death. 2010 Int J Cell Biol pmid:20182529
Dong Y et al. Neuroprotective effects and impact on caspase-12 expression of tauroursodeoxycholic acid after acute spinal cord injury in rats. 2015 Int J Clin Exp Pathol pmid:26884858
Paridaens A et al. Modulation of the Unfolded Protein Response by Tauroursodeoxycholic Acid Counteracts Apoptotic Cell Death and Fibrosis in a Mouse Model for Secondary Biliary Liver Fibrosis. 2017 Int J Mol Sci pmid:28117681
Lim SC et al. Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma. 2010 Int. J. Cancer pmid:19728331
Boost KA et al. c-Met responsiveness of isolated hepatocytes evaluated in an in vitro de-differentiation model. 2006 Int. J. Mol. Med. pmid:16465395
Fernández-Sánchez L et al. Tauroursodeoxycholic acid prevents retinal degeneration in transgenic P23H rats. 2011 Invest. Ophthalmol. Vis. Sci. pmid:21508111
Drack AV et al. TUDCA slows retinal degeneration in two different mouse models of retinitis pigmentosa and prevents obesity in Bardet-Biedl syndrome type 1 mice. 2012 Invest. Ophthalmol. Vis. Sci. pmid:22110077
Phillips MJ et al. Tauroursodeoxycholic acid preservation of photoreceptor structure and function in the rd10 mouse through postnatal day 30. 2008 Invest. Ophthalmol. Vis. Sci. pmid:18436848
Zhang T et al. Chemical chaperone TUDCA preserves cone photoreceptors in a mouse model of Leber congenital amaurosis. 2012 Invest. Ophthalmol. Vis. Sci. pmid:22531707
Qiao X et al. Differentiation of various traditional Chinese medicines derived from animal bile and gallstone: simultaneous determination of bile acids by liquid chromatography coupled with triple quadrupole mass spectrometry. 2011 J Chromatogr A pmid:21111425
Kanazawa I Therapeutic Strategies in Huntington's Disease. 2006 J Clin Neurol pmid:20396523
Colak A et al. Tauroursodeoxycholic acid and secondary damage after spinal cord injury in rats. 2008 J Clin Neurosci pmid:18343118
Bikbova G et al. Altered Expression of NF- κ B and SP1 after Exposure to Advanced Glycation End-Products and Effects of Neurotrophic Factors in AGEs Exposed Rat Retinas. 2015 J Diabetes Res pmid:26078979
Feng Y et al. Bear bile: dilemma of traditional medicinal use and animal protection. 2009 J Ethnobiol Ethnomed pmid:19138420
Noailles A et al. Microglia activation in a model of retinal degeneration and TUDCA neuroprotective effects. 2014 J Neuroinflammation pmid:25359524
Yanguas-Casás N et al. Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation. 2014 J Neuroinflammation pmid:24645669
Woo SJ et al. Ursodeoxycholic acid and tauroursodeoxycholic acid suppress choroidal neovascularization in a laser-treated rat model. 2010 J Ocul Pharmacol Ther pmid:20565307
Simoni P et al. A new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load. 2013 Jul-Aug J Pharm Biomed Anal pmid:23587552
Higuchi WI et al. Estimation of cholesterol solubilization by a mixed micelle binding model in aqueous tauroursodeoxycholate:lecithin:cholesterol solutions. 2008 J Pharm Sci pmid:17786967
Fu J et al. Endoplasmic reticulum stress is involved in 2,4-dichlorophenol-induced hepatotoxicity. 2016 J Toxicol Sci pmid:27853103
Cardoso I et al. Synergy of combined doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models. 2010 J Transl Med pmid:20673327
Cursio R and Gugenheim J Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation. 2012 J Transplant pmid:22530107
Viana RJ et al. Modulation of amyloid-β peptide-induced toxicity through inhibition of JNK nuclear localization and caspase-2 activation. 2010 J. Alzheimers Dis. pmid:20847398
Fonseca MB et al. c-Jun regulates the stability of anti-apoptotic ΔNp63 in amyloid-β-induced apoptosis. 2012 J. Alzheimers Dis. pmid:22045494
Viana RJ et al. Amyloid-β peptide-induced secretion of endoplasmic reticulum chaperone glycoprotein GRP94. 2011 J. Alzheimers Dis. pmid:21750376
de Almeida SF et al. Chemical chaperones reduce endoplasmic reticulum stress and prevent mutant HFE aggregate formation. 2007 J. Biol. Chem. pmid:17626021
Sabeva NS et al. Defects in the leptin axis reduce abundance of the ABCG5-ABCG8 sterol transporter in liver. 2007 J. Biol. Chem. pmid:17561514
Schmidt DR et al. Regulation of bile acid synthesis by fat-soluble vitamins A and D. 2010 J. Biol. Chem. pmid:20233723